Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio.
Industry, Sector and Symbol
Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
Phone513-762-6690
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.78 billion
Profitability
Miscellaneous
Employees15,707
Next Earnings Date4/29/2019 (Confirmed)
OptionableOptionable
Chemed (NYSE:CHE) Frequently Asked Questions
What is Chemed's stock symbol?
Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."
How often does Chemed pay dividends? What is the dividend yield for Chemed?
Chemed announced a quarterly dividend on Friday, February 22nd. Shareholders of record on Monday, March 4th will be paid a dividend of $0.30 per share on Friday, March 22nd. This represents a $1.20 annualized dividend and a yield of 0.36%. The ex-dividend date of this dividend is Friday, March 1st. View Chemed's Dividend History.
How will Chemed's stock buyback program work?
Chemed declared that its board has approved a stock repurchase program on Wednesday, March 7th 2018, which allows the company to buyback $150,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Stock buyback programs are often a sign that the company's leadership believes its stock is undervalued.
How were Chemed's earnings last quarter?
Chemed Co. (NYSE:CHE) released its earnings results on Wednesday, February, 20th. The company reported $3.35 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $3.27 by $0.08. The firm had revenue of $457.51 million for the quarter, compared to analyst estimates of $460.50 million. Chemed had a return on equity of 36.06% and a net margin of 11.53%. The company's quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $2.32 earnings per share. View Chemed's Earnings History.
When is Chemed's next earnings date?
What guidance has Chemed issued on next quarter's earnings?
Chemed updated its FY19 earnings guidance on Wednesday, February, 20th. The company provided EPS guidance of $12.65-12.85 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.54. Chemed also updated its FY 2019 guidance to $12.65-12.85 EPS.
What price target have analysts set for CHE?
2 analysts have issued 1-year price objectives for Chemed's shares. Their forecasts range from $318.00 to $390.00. On average, they expect Chemed's stock price to reach $354.00 in the next twelve months. This suggests a possible upside of 7.6% from the stock's current price. View Analyst Price Targets for Chemed.
What is the consensus analysts' recommendation for Chemed?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.
Has Chemed been receiving favorable news coverage?
News stories about CHE stock have been trending very positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Chemed earned a daily sentiment score of 3.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future.
Who are some of Chemed's key competitors?
What other stocks do shareholders of Chemed own?
Who are Chemed's key executives?
Chemed's management team includes the folowing people:
- Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
- Mr. David P. Williams, Exec. VP & CFO (Age 58)
- Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
- Mr. Spencer S. Lee, Exec. VP (Age 63)
- Mr. Nicholas Michael Westfall, Exec. VP (Age 40)
Who are Chemed's major shareholders?
Chemed's stock is owned by a number of of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (2.72%), Investec Asset Management LTD (1.58%), BTIM Corp. (0.72%), Boston Advisors LLC (0.05%), Investec Asset Management PTY Ltd (0.04%) and Hanson & Doremus Investment Management (0.04%). Company insiders that own Chemed stock include David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice. View Institutional Ownership Trends for Chemed.
Which major investors are selling Chemed stock?
CHE stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Boston Advisors LLC, Investec Asset Management LTD, State of Alaska Department of Revenue, Strs Ohio, Eqis Capital Management Inc., Hanson & Doremus Investment Management and First Hawaiian Bank. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice. View Insider Buying and Selling for Chemed.
Which major investors are buying Chemed stock?
CHE stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Mercer Global Advisors Inc. ADV, Meeder Asset Management Inc., BB&T Corp, McAdam LLC, We Are One Seven LLC, BTIM Corp. and TrimTabs Asset Management LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.
How do I buy shares of Chemed?
Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemed's stock price today?
One share of CHE stock can currently be purchased for approximately $328.88.
How big of a company is Chemed?
Chemed has a market capitalization of $5.24 billion and generates $1.78 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $11.93 on an earnings per share basis. Chemed employs 15,707 workers across the globe.
What is Chemed's official website?
How can I contact Chemed?
Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.
MarketBeat Community Rating for Chemed (NYSE CHE)
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
